Financial Results
Ibnsina Pharma (ISPH.CA) Reports Its Financial Results (Consolidated) for The Period From 01/01/2026 to 31/03/2026
AI Summary
AI-powered disclosure summary — Coming soon 🔜
Company Name: Ibnsina Pharma
ISIN Code: EGS512O1C012
Currency: Egyptian Pound
F/S (Consolidated) Period: From 01/01/2026 to 31/03/2026
Net profit: 255,936,016
F/S (Consolidated) Period: From 01/01/2025 to 31/03/2025
Net Comparative profit: 181,880,957
Audit Status: Reviewed
Source: Ibnsina Pharma
Taking minority rights into consideration
ISIN Code: EGS512O1C012
Currency: Egyptian Pound
F/S (Consolidated) Period: From 01/01/2026 to 31/03/2026
Net profit: 255,936,016
F/S (Consolidated) Period: From 01/01/2025 to 31/03/2025
Net Comparative profit: 181,880,957
Audit Status: Reviewed
Source: Ibnsina Pharma
Taking minority rights into consideration